Academic Bibliography

Search 200 years of publications by Ghent University researchers.

dr. Iebe Rossey

Faculty of Sciences > Department of Biochemistry and microbiology

ORCID iD: 0000-0002-0795-972X

Add to list
- Journal Article
- A1
- open access
Direct and ultrasensitive bioluminescent detection of intact respiratory viruses

Alexander Gräwe, Harm van der Veer, Seino A. K. Jongkees, Jacky Flipse, Iebe Rossey (UGent) , Robert P. de Vries, Xavier Saelens (UGent) and Maarten Merkx

(2024) ACS SENSORS. 9(10). p.5550-5560
Add to list
- Journal Article
- A1
- open access
GlycoVHH : optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery

Loes van Schie (UGent) , Wander Van Breedam (UGent) , Charlotte Roels (UGent) , Bert Schepens (UGent) , Martin Frank, Ahmadreza Mehdipour (UGent) , Bram Laukens, Wim Nerinckx (UGent) , Francis Santens, Simon Devos (UGent) , et al.

(2023) MABS. 15(1).
Add to list
- Journal Article
- A1
- open access
How RSV proteins join forces to overcome the host innate immune response

Tessa Van Royen, Iebe Rossey (UGent) , Koen Sedeyn (UGent) , Bert Schepens (UGent) and Xavier Saelens (UGent)

(2022) VIRUSES. 14(2).
Add to list
- Miscellaneous
GlycoVHH : introducing N-glycans on the camelid VHH antibody scaffold : optimal sites and use for macrophage delivery

Loes van Schie (UGent) , Wander Van Breedam (UGent) , Charlotte Roels (UGent) , Bert Schepens (UGent) , Martin Frank, Ahmadreza Mehdipour (UGent) , Bram Laukens, Wim Nerinckx (UGent) , Francis Santens, Simon Devos (UGent) , et al.

(2022) BioRXiv.
Add to list
- Journal Article
- A1
- open access
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models

Bert Schepens (UGent) , Loes van Schie (UGent) , Wim Nerinckx (UGent) , Kenny Roose (UGent) , Wander Van Breedam (UGent) , Daria Fijalkowska (UGent) , Simon Devos (UGent) , Wannes Weyts (UGent) , Sieglinde De Cae (UGent) , Sandrine Vanmarcke (UGent) , et al.

(2021) SCIENCE TRANSLATIONAL MEDICINE. 13(621).
Add to list
A vulnerable, membrane-proximal site in human respiratory syncytial virus F revealed by a prefusion-specific single-domain antibody

Iebe Rossey (UGent) , Ching-Lin Hsieh, Koen Sedeyn (UGent) , Marlies Ballegeer (UGent) , Bert Schepens (UGent) , Jason S. McLellan and Xavier Saelens (UGent)

(2021) JOURNAL OF VIROLOGY. 95(11).
Add to list
Vaccines against human respiratory syncytial virus in clinical trials, where are we now?

Iebe Rossey (UGent) and Xavier Saelens (UGent)

(2019) EXPERT REVIEW OF VACCINES. 18(10). p.1053-1067
Add to list
- Journal Article
- A2
- open access
Single-domain antibodies and their formatting to combat viral infections

Dorien De Vlieger, Marlies Ballegeer (UGent) , Iebe Rossey (UGent) , Bert Schepens (UGent) and Xavier Saelens (UGent)

(2018) ANTIBODIES. 8(1).
Add to list
Clinical potential of prefusion RSV F-specific antibodies

Iebe Rossey (UGent) , Jason S McLellan, Xavier Saelens (UGent) and Bert Schepens (UGent)

(2018) TRENDS IN MICROBIOLOGY. 26(3). p.209-219
Add to list
- Journal Article
- A1
- open access
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state

Iebe Rossey (UGent) , Morgan SA Gilman, Stephanie C Kabeche, Koen Sedeyn (UGent) , Daniel Wrapp, Masaru Kanekiyo, Man Chen, Vicente Mas, Jan Spitaels (UGent) , José A Melero, et al.

(2017) NATURE COMMUNICATIONS. 8.

1
2

Next →